PHILADELPHIA, April 23, 2014 /PRNewswire/ --
Stanson's next-generation clinical
decision support and analytics solution fully integrates into EMRs,
provides alerts to help providers keep care costs low, quality
high
Elsevier, a world-leading provider of scientific, technical and
medical information products and services, announced today an
agreement to market Stanson Health's next-generation clinical
decision support (CDS) and analytics solution. Stanson's CDS
solutions are designed to safely reduce the cost and potential for
harm from unnecessary care by leveraging user-friendly, real-time
alerts and analytics to help guide physicians' decisions.
Stanson's CDS solutions complement the Elsevier Clinical
Solutions suite, which includes a portfolio of solutions for
workflow and decision support, clinical reference and drug
reference, patient engagement and performance management.
As the healthcare industry evolves, healthcare payers (i.e.,
insurance companies, the government) are counting on physicians and
hospitals to control and even reduce costs as they improve the
quality of care. Unnecessary or inappropriate care accounts for a
significant amount of the overall healthcare spend, and more than
80 percent of overall healthcare costs are directly linked to
decisions made by physicians.
Stanson Health, a population health, CDS and analytics company,
provides previously tested and validated CDS alerts, which reduce
the potential for "false positive" alerts that cause alert fatigue.
The alerts are designed to reduce unnecessary care for patient
populations across the continuum, in physician offices, emergency
departments and hospitals. The CDS recommendations are based on
widely accepted guidelines, including from Choosing Wisely®, an
initiative of the ABIM Foundation. The analytics solution provides
comparative information on physician acceptance and rejection of
CDS recommendations and provides "utilization fingerprints" that
are used to inform discussions about high quality and
cost-effective care.
"With the transition toward population health and payment
reform, and the improvement in EHR functionality, we believe that
there is need for the next generation of CDS," said Scott Weingarten, MD, Chairman of Stanson
Health. "The CDS should be integrated into the workflow,
personalized for each patient, accompanied by analytics and tested
prior to release to reduce false-positives, impact care across the
continuum, safely reduce costs and improve quality."
Weingarten was the co-founder and CEO of Zynx Health for 16
years. Stanson Health's CDS and analytics solution was first
implemented at Cedars-Sinai Health System, where it demonstrated
statistically significant improvements in the quality of patient
care and reductions in inappropriate care.
For example, with Stanson Health, a physician can compare how
often he or she accepts and rejects Choosing Wisely guidelines
related to performing CT scans for patients with chronic
isolated headache with other physicians at that organization. This
information can be very useful as physician organizations prepare
for health care reform, ACOs, risk-based payments, exchanges, and
narrow networks.
"By providing a CDS alert system to physicians at the point of
decision, we hope to enable physicians to make more valuable
clinical decisions that are based on evidence and help reduce
unnecessary and costly care," said Jay
Katzen, President of Elsevier Clinical Solutions. "This CDS
tool is a great complement to our portfolio of workflow solutions
delivering order sets, care planning and documentation, and drug
decision support. Based on the positive reviews from the physicians
who trialed the Stanson product, we expect to take a significant
step forward in helping our customers improve care and reduce costs
with this CDS tool."
For more information about Stanson Health CDS alerts and
analytics from Elsevier, please contact us at
CDSAlerts@elsevier.com.
---
About Stanson Health
Headquartered in Los Angeles,
CA, Stanson Health LLC is leading the way
in the development of the next generation CDS
solutions. Stanson provides integrated real time alerts optimized
for use in the physician's clinical workflow. Combined with
relevant analytics, Stanson solutions safely guide physician's
decisions toward the elimination of unnecessary or inappropriate
care and helps improve the quality of care. Health care
systems and organizations preparing for payment
reform and population
health recognize that Stanson Health solutions
deliver the most effective cost reducing CDS available today. To
learn more, visit stansonhealth.com or call +1 310
444 7179.
About Elsevier
Elsevier is a world-leading provider of information solutions
that enhance the performance of science, health, and technology
professionals, empowering them to make better decisions, deliver
better care, and sometimes make groundbreaking discoveries that
advance the boundaries of knowledge and human progress. Elsevier
provides web-based, digital solutions - among them
ScienceDirect, Scopus, Elsevier Research Intelligence and
ClinicalKey - and publishes nearly 2,200 journals, including The
Lancet and Cell, and over 25,000 book titles, including
a number of iconic reference works.
The company is part of Reed Elsevier Group PLC, a world-leading
provider of professional information solutions in the Science,
Medical, Legal and Risk and Business sectors, which is jointly
owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols
are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and
ENL (New York Stock Exchange).
Media contact
Christopher Capot
Director, Corporate Relations
Elsevier
+1-212-633-3164
c.capot@elsevier.com